For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
10
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      197
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Kidney cancer: Somatic mutations predict survival duration

      Author(s):
      Publication date Created:
      Publication date (Print):
      Journal: Nature Reviews Urology
      Publisher: Springer Nature

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Data from a genetic analysis of a cohort of patients with metastatic renal cell carcinoma (mRCC) receiving everolimus or sunitinib as part of the RECORD-3 trial reveal that the presence of certain somatic mutations is associated with superior progression-free survival (PFS) outcomes. Patients with mutations

          Related collections

          Author and article information

          Journal
          Title: Nature Reviews Urology
          Abbreviated Title: Nat Rev Urol
          Publisher: Springer Nature
          ISSN (Print): 1759-4812
          ISSN (Electronic): 1759-4820
          Publication date Created: November 8 2016
          Publication date (Print): November 8 2016
          Volume: 14
          Issue: 1
          Page: 9
          Article
          DOI: 10.1038/nrurol.2016.235
          SO-VID: 7dd80ea6-6712-40cc-b00a-7dd58d5716d9
          Copyright © © 2016
          History

          Data availability:

          Comments

          Comment on this article